Capital Square’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$227K Buy
2,630
+51
+2% +$4.5K 0.1% 212
2026
Q2
$216K Buy
+2,579
New +$208K 0.1% 216
2026
Q1
– Sell
-2,218
Closed -$213K – 242
2025
Q4
$213K Buy
+2,218
New +$215K 0.11% 196
2022
Q3
– Sell
-3,749
Closed -$336K – 141
2022
Q2
$336K Sell
3,749
-502
-12% -$50.9K 0.28% 89
2022
Q1
$471K Buy
4,251
+318
+8% +$33.6K 0.34% 87
2021
Q4
$416K Sell
3,933
-342
-8% -$39.6K 0.29% 96
2021
Q3
$544K Buy
+4,275
New +$553K 0.39% 82
2021
Q2
– Sell
-4,479
Closed -$546K – 155
2021
Q1
$546K Buy
4,479
+556
+14% +$65.2K 0.41% 77
2020
Q4
$459K Buy
3,923
+67
+2% +$7.38K 0.38% 86
2020
Q3
$400K Buy
3,856
+920
+31% +$92.4K 0.41% 83
2020
Q2
$269K Buy
2,936
+303
+12% +$29.1K 0.29% 108
2020
Q1
$237K Buy
+2,633
New +$280K 0.28% 100

Other funds holding MDT

Capital Square's MDT Position: Q3 2026 in Review

Capital Square increased its Medtronic (MDT) stake by 2% in Q3 2026, buying an estimated $4.5K and bringing the position to 2,630 shares worth $227K. The position accounts for 0.1% of the portfolio, ranked #212.

Capital Square first reported a position in MDT in Q1 2020 and has held it in 12 quarters since. The position peaked at $546K in Q1 2021. 811 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Capital Square held 2,630 shares of Medtronic worth $227K as of Q3 2026.
  • Capital Square bought 51 Medtronic shares in Q3 2026, an estimated $4.5K.
  • Medtronic made up 0.1% of Capital Square's portfolio in Q3 2026, its #212 holding.
  • Capital Square first reported a position in Medtronic in Q1 2020 and has held it in 12 quarters since.
  • Capital Square's Medtronic position peaked at $546K in Q1 2021.
  • 811 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Capital Square's 13F filing for Q3 2026, filed 19 Oct 2026.